ABIVAX Société Anonyme Balance Sheet Health
Financial Health criteria checks 5/6
ABIVAX Société Anonyme has a total shareholder equity of €80.5M and total debt of €40.4M, which brings its debt-to-equity ratio to 50.1%. Its total assets and total liabilities are €171.1M and €90.6M respectively.
Key information
50.1%
Debt to equity ratio
€40.36m
Debt
Interest coverage ratio | n/a |
Cash | €114.38m |
Equity | €80.49m |
Total liabilities | €90.59m |
Total assets | €171.08m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABVXp's short term assets (€130.4M) exceed its short term liabilities (€46.2M).
Long Term Liabilities: ABVXp's short term assets (€130.4M) exceed its long term liabilities (€44.4M).
Debt to Equity History and Analysis
Debt Level: ABVXp has more cash than its total debt.
Reducing Debt: ABVXp's debt to equity ratio has increased from 0% to 50.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ABVXp has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ABVXp is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.